| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 226.26B | 213.57B | 188.87B | 185.48B | 181.33B |
| Gross Profit | 89.80B | 78.18B | 63.49B | 59.31B | 59.88B |
| EBITDA | 123.18B | 113.37B | 94.88B | 90.23B | 90.56B |
| Net Income | 47.89B | 35.08B | 29.09B | 26.01B | 26.92B |
Balance Sheet | |||||
| Total Assets | 420.27B | 431.43B | 454.44B | 337.04B | 356.22B |
| Cash, Cash Equivalents and Short-Term Investments | 25.97B | 22.61B | 14.74B | 10.04B | 14.33B |
| Total Debt | 192.21B | 213.63B | 242.38B | 128.42B | 138.96B |
| Total Liabilities | 312.99B | 334.11B | 363.76B | 251.23B | 274.40B |
| Stockholders Equity | 107.18B | 97.22B | 90.58B | 85.69B | 81.70B |
Cash Flow | |||||
| Free Cash Flow | 73.67B | 78.61B | 36.65B | 38.05B | 41.34B |
| Operating Cash Flow | 120.81B | 116.62B | 87.64B | 81.40B | 86.63B |
| Investing Cash Flow | -47.24B | -36.93B | -77.99B | -43.00B | -45.35B |
| Financing Cash Flow | -70.83B | -71.83B | -3.93B | -42.14B | -46.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $25.14B | 23.84 | 8.36% | 5.03% | -3.16% | 4.70% | |
75 Outperform | $20.30B | 15.49 | 15.54% | 6.14% | -5.21% | -7.45% | |
73 Outperform | $37.05B | 25.56 | 45.87% | 2.67% | 14.95% | 40.15% | |
72 Outperform | $32.87B | 26.68 | 10.10% | 3.15% | 5.74% | 7.12% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | $36.18B | -8.50 | -7.08% | 3.77% | 19.67% | -278.51% |